Protein kinase C regulates mood-related behaviors and adult hippocampal cell proliferation in rats

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 43, Issue , 2013, Pages 40-48

  Abrial, Erika ^a,b,c   Etievant, Adeline ^a,b,c   Bétry, Cécile ^a,b,c   Scarna, Hélène ^a,b,c   Lucas, Guillaume ^a,b,c   Haddjeri, Nasser ^a,b,c   Lambás Señas, Laura ^a,b,c  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

^c STEM CELL AND BRAIN RESEARCH INSTITUTE   (France)

Author keywords

Behavior; Bipolar disorder; Depression; Hippocampal cell proliferation; Mania; Protein kinase C

Indexed keywords

AMPHETAMINE; CHELERYTHRINE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; TAMOXIFEN;

ADULT ANIMAL; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIPOLAR DISORDER; BRAIN NERVE CELL; CELL PROLIFERATION; CONTROLLED STUDY; DENTATE GYRUS; DEPRESSION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; FORCED SWIMMING TEST; GROWTH INHIBITION; HIGH RISK BEHAVIOR; HIPPOCAMPUS; HYPERACTIVITY; IMMUNOHISTOCHEMISTRY; LONG TERM EXPOSURE; MALE; MANIA; MAZE TEST; MOOD CHANGE; NONHUMAN; OPEN FIELD TEST; RAT; SIGNAL TRANSDUCTION;

AFFECT; ANIMALS; ANTIMETABOLITES; ANXIETY; BEHAVIOR, ANIMAL; BIPOLAR DISORDER; BROMODEOXYURIDINE; CELL COUNT; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM STIMULANTS; DENTATE GYRUS; DEPRESSION; DEXTROAMPHETAMINE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MICROINJECTIONS; MOTOR ACTIVITY; NEURONAL PLASTICITY; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; RATS; RISK-TAKING; SIGNAL TRANSDUCTION; STEREOTAXIC TECHNIQUES; SWIMMING;

EID: 84871964101     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2012.11.015     Document Type: Article

References (66)

1. Abrial E., Lucas G., Scarna H., Haddjeri N., Lambás-Señas L. A role for the PKC signaling system in the pathophysiology and treatment of mood disorders: involvement of a functional imbalance?. Mol Neurobiol 2011, 44:407-419.
2. Alfonso J., Frick L.R., Silberman D.M., Palumbo M.L., Genaro A.M., Frasch A.C. Regulation of hippocampal gene expression is conserved in two species subjected to different stressors and antidepressant treatments. Biol Psychiatry 2006, 59:244-251.
3. Ali S.M., Ahmad A., Shahabuddin S., Ahmad M.U., Sheikh S., Ahmad I. Endoxifen is a new potent inhibitor of PKC: a potential therapeutic agent for bipolar disorder. Bioorg Med Chem Lett 2010, 20:2665-2667.
4. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, Washington, DC. Revised 4th ed.
5. Amrollahi Z., Rezaei F., Salehi B., Modabbernia A.-H., Maroufi A., Esfandiari G.-R., et al. Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania. J Affect Disord 2010, 129:327-331.
6. Arnsten A, Birnbaum S, 2005. Chelerythrine, analogs thereof and their use in the treatment of bipolar disorder and other cognitive disorders. Patent WO/2005/030143, issued April 7, 2005.
7. Barbier E., Wang J.B. Anti-depressant and anxiolytic like behaviors in PKCI/HINT1 knockout mice associated with elevated plasma corticosterone level. BMC Neurosci 2009, 10:132.
8. Barha C.K., Galea L.A.M. Influence of different estrogens on neuroplasticity and cognition in the hippocampus. Biochim Biophys Acta 2010, 1800:1056-1067.
9. Basta-Kaim A., Budziszewska B., Jaworska-Feil L., Tetich M., Kubera M., Leśkiewicz M., et al. Antipsychotic drugs inhibit the human corticotropin-releasing-hormone gene promoter activity in neuro-2A cells-an involvement of protein kinases. Neuropsychopharmacology 2006, 31:853-865.
10. Bebchuk J.M., Arfken C.L., Dolan-Manji S., Murphy J., Hasanat K., Manji H.K. A preliminary investigation of a protein kinase C inhibitor in the treatment of acute mania. Arch Gen Psychiatry 2000, 57:95-97.
11. Benes F.M., Kwok E.W., Vincent S.L., Todtenkopf M.S. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry 1998, 44:88-97.
12. Birnbaum S.G., Yuan P.X., Wang M., Vijayraghavan S., Bloom A.K., Davis D.J., et al. Protein kinase C overactivity impairs prefrontal cortical regulation of working memory. Science 2004, 306:882-884.
13. Carobrez A.P., Bertoglio L.J. Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on. Neurosci Biobehav Rev 2005, 29:1193-1205.
14. Drevets W.C., Price J.L., Furey M.L. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct 2008, 213:93-118.
15. Dwivedi Y., Mondal A.C., Rizavi H.S., Shukla P.K., Pandey G.N. Single and repeated stress-induced modulation of phospholipase C catalytic activity and expression: role in LH behavior. Neuropsychopharmacology 2005, 30:473-483.
16. Einat H., Manji H.K. Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder. Biol Psychiatry 2006, 59:1160-1171.
17. Einat H., Manji H.K., Gould T.D., Du J., Chen G. Possible involvement of the ERK signaling cascade in bipolar disorder: behavioral leads from the study of mutant mice. Drug News Perspect 2003, 16:453-463.
18. Einat H., Yuan P., Szabo S.T., Dogra S., Manji H.K. Protein kinase C inhibition by tamoxifen antagonizes manic-like behavior in rats: implications for the development of novel therapeutics for bipolar disorder. Neuropsychobiology 2007, 55:123-131.
19. Fanselow M.S., Dong H.-W. Are the dorsal and ventral hippocampus functionally distinct structures?. Neuron 2010, 65:7-19.
20. Frey B., Valvassori S., Réus G., Martins M., Petronilho F., Bardini K., et al. Changes in antioxidant defense enzymes after d-amphetamine exposure: implications as an animal model of mania. Neurochem Res 2006, 31:699-703.
21. Frey B.N., Valvassori S.S., Réus G.Z., Martins M.R., Petronilho F.C., Bardini K., et al. Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. J Psychiatry Neurosci 2006, 31:326-332.
22. Friedman E., Wang H.Y., Levinson D., Connell T.A., Singh H. Altered platelet protein kinase C activity in bipolar affective disorder, manic episode. Biol Psychiatry 1993, 33:520-525.
23. Galeotti N., Ghelardini C. Antidepressant phenotype by inhibiting the phospholipase Cβ(1)-protein kinase Cγ pathway in the forced swim test. Neuropharmacology 2011, 60:937-943.
24. Goldin M., Segal M. Protein kinase C and ERK involvement in dendritic spine plasticity in cultured rodent hippocampal neurons. Eur J Neurosci 2003, 17:2529-2539.
25. Grote H.E., Hannan A.J. Regulators of adult neurogenesis in the healthy and diseased brain. Clin Exp Pharmacol Physiol 2007, 34:533-545.
26. Hahn C.-G., Umapathy C., Wang H.-Y., Koneru R., Levinson D.F., Friedman E. Lithium and valproic acid treatments reduce PKC activation and receptor-G protein coupling in platelets of bipolar manic patients. J Psychiatr Res 2005, 39:355-363.
27. Hajek T., Kopecek M., Höschl C., Alda M. Smaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: a meta-analysis. J Psychiatry Neurosci 2012, 37:333-343.
28. Herbert J.M., Augereau J.M., Gleye J., Maffrand J.P. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 1990, 172:993-999.
29. Hsieh J., Nakashima K., Kuwabara T., Mejia E., Gage F.H. Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc Natl Acad Sci U S A 2004, 101:16659-16664.
30. Jensen J.B., Mørk A. Altered protein phosphorylation in the rat brain following chronic lithium and carbamazepine treatments. Eur Neuropsychopharmacol 1997, 7:173-179.
31. Juetten J., Einat H. Behavioral differences in black Swiss mice from separate colonies: implications for modeling domains of mania. Behav Pharmacol 2012, 23:211-214.
32. Kataoka M., Yamamori S., Suzuki E., Watanabe S., Sato T., Miyaoka H., et al. A single amino acid mutation in SNAP-25 induces anxiety-related behavior in mouse. PLoS One 2011, 6:e25158.
33. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005, 62:593-602.
34. Kim D.H., Jung J.S., Kim H.S., Suh H.W., Son B.K., Kim Y.H., et al. Inhibition of brain protein kinase C attenuates immobilization stress-induced plasma corticosterone levels in mice. Neurosci Lett 2000, 291:69-72.
35. Korshunova I., Novitskaya V., Kiryushko D., Pedersen N., Kolkova K., Kropotova E., et al. GAP-43 regulates NCAM-180-mediated neurite outgrowth. J Neurochem 2007, 100:1599-1612.
36. Kulkarni J., Garland K.A., Scaffidi A., Headey B., Anderson R., de Castella A., et al. A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder. Psychoneuroendocrinology 2006, 31:543-547.
37. Lopez A.D., Mathers C.D., Ezzati M., Jamison D.T., Murray C.J.L. Global burden of disease and risk factors 2006, Oxford University Press, New York. 1st ed.
38. Malberg J.E., Duman R.S. Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology 2003, 28:1562-1571.
39. Manji H.K., Lenox R.H. Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness. Biol Psychiatry 1999, 46:1328-1351.
40. Moriguchi S., Han F., Nakagawasai O., Tadano T., Fukunaga K. Decreased calcium/calmodulin-dependent protein kinase II and protein kinase C activities mediate impairment of hippocampal long-term potentiation in the olfactory bulbectomized mice. J Neurochem 2006, 97:22-29.
41. Nelson T.J., Cui C., Luo Y., Alkon D.L. Reduction of beta-amyloid levels by novel protein kinase C(epsilon) activators. J Biol Chem 2009, 284:34514-34521.
42. Palumbo M.L., Zorrilla Zubilete M.A., Cremaschi G.A., Genaro A.M. Different effect of chronic stress on learning and memory in BALB/c and C57BL/6 inbred mice: involvement of hippocampal NO production and PKC activity. Stress 2009, 12:350-361.
43. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2007, Elsevier, San Diego. 6th ed.
44. Porsolt R.D., Anton G., Blavet N., Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 1978, 47:379-391.
45. Prut L., Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 2003, 463:3-33.
46. Rajkowska G. Cell pathology in bipolar disorder. Bipolar Disord 2002, 4:105-116.
47. Ramakers G.M., Pasinelli P., Hens J.J., Gispen W.H., De Graan P.N. Protein kinase C in synaptic plasticity: changes in the in situ phosphorylation state of identified pre- and postsynaptic substrates. Prog Neuropsychopharmacol Biol Psychiatry 1997, 21:455-486.
48. Reyland M.E. Protein kinase C isoforms: multi-functional regulators of cell life and death. Front Biosci 2009, 14:2386-2399.
49. Robinson S.P., Langan-Fahey S.M., Johnson D.A., Jordan V.C. Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient. Drug Metab Dispos 1991, 19:36-43.
50. Rowlands M.G., Budworth J., Jarman M., Hardcastle I.R., McCague R., Gescher A. Comparison between inhibition of protein kinase C and antagonism of calmodulin by tamoxifen analogues. Biochem Pharmacol 1995, 50:723-726.
51. Sabioni P., Baretta I.P., Ninomiya E.M., Gustafson L., Rodrigues A.L.S., Andreatini R. The antimanic-like effect of tamoxifen: behavioural comparison with other PKC-inhibiting and antiestrogenic drugs. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:1927-1931.
52. Salvadore G., Quiroz J.A., Machado-Vieira R., Henter I.D., Manji H.K., Zarate C.A. The neurobiology of the switch process in bipolar disorder: a review. J Clin Psychiatry 2010, 71:1488-1501.
53. Samuels B.A., Hen R. Neurogenesis and affective disorders. Eur J Neurosci 2011, 33:1152-1159.
54. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003, 301:805-809.
55. Schloesser R.J., Chen G., Manji H.K. Neurogenesis and neuroenhancement in the pathophysiology and treatment of bipolar disorder. Int Rev Neurobiol 2007, 77:143-178.
56. Steckert A.V., Valvassori S.S., Mina F., Lopes-Borges J., Varela R.B., Kapczinski F., et al. Protein kinase C and oxidative stress in an animal model of mania. Curr Neurovasc Res 2012, 9:47-57.
57. Sun M.-K., Alkon D.L. Dual effects of bryostatin-1 on spatial memory and depression. Eur J Pharmacol 2005, 512:43-51.
58. Vianna M.R., Barros D.M., Silva T., Choi H., Madche C., Rodrigues C., et al. Pharmacological demonstration of the differential involvement of protein kinase C isoforms in short- and long-term memory formation and retrieval of one-trial avoidance in rats. Psychopharmacology (Berl) 2000, 150:77-84.
59. Vollmayr B., Simonis C., Weber S., Gass P., Henn F. Reduced cell proliferation in the dentate gyrus is not correlated with the development of learned helplessness. Biol Psychiatry 2003, 54:1035-1040.
60. Wesołowska A., Partyka A., Jastrzebska-Wiesek M., Kolarz A., Mierzejewski P., Bieńkowski P., et al. Tail suspension test does not detect antidepressant-like properties of atypical antipsychotics. Behav Pharmacol 2010, 22:7-13.
61. Wu J., Song T.-B., Li Y.-J., He K.-S., Ge L., Wang L.-R. Prenatal restraint stress impairs learning and memory and hippocampal PKCbeta1 expression and translocation in offspring rats. Brain Res 2007, 1141:205-213.
62. Yildiz A., Guleryuz S., Ankerst D.P., Ongür D., Renshaw P.F. Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen. Arch Gen Psychiatry 2008, 65:255-263.
63. Yu I.T., Park J.-Y., Kim S.H., Lee J., Kim Y.-S., Son H. Valproic acid promotes neuronal differentiation by induction of proneural factors in association with H4 acetylation. Neuropharmacology 2009, 56:473-480.
64. Zarate C.A., Manji H.K. Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder. C.N.S. Drugs 2009, 23:569-582.
65. Zarate C.A., Singh J.B., Carlson P.J., Quiroz J., Jolkovsky L., Luckenbaugh D.A., et al. Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study. Bipolar Disord 2007, 9:561-570.
66. Zeidman R., Pettersson L., Sailaja P.R., Truedsson E., Fagerström S., Påhlman S., et al. Novel and classical protein kinase C isoforms have different functions in proliferation, survival and differentiation of neuroblastoma cells. Int J Cancer 1999, 81:494-501.